Impact of Pharmacists' audit on improving the quality of prescription of dabigatran etexilate methanesulfonate: a retrospective study.

Shimizu, Teppei; Momose, Yoshio; Ogawa, Ryuichi; Takahashi, Masahiro; Echizen, Hirotoshi

Shimizu, Teppei; Momose, Yoshio; Ogawa, Ryuichi; Takahashi, Masahiro; Echizen, Hirotoshi.

Afiliação

Shimizu T; Department of Hospital Pharmacy, Kitahara International Hospital, 1-7-23 Owada-machi, Hachioji, Tokyo 192-0045 Japan ; Department of Pharmacotherapy, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588 Japan.
Momose Y; Departments of Neurology, Kitahara International Hospital, 1-7-23 Owada-machi, Hachioji, Tokyo 192-0045 Japan.
Ogawa R; Department of Pharmacotherapy, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588 Japan.
Takahashi M; Department of Pharmacotherapy, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588 Japan.
Echizen H; Department of Pharmacotherapy, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588 Japan.

J Pharm Health Care Sci ; 3: 4, 2017.

Article em En | MEDLINE | ID: mdl-28116115

Palavras-chave

Dabigatran; Electronic medical records; Hospital pharmacists; Prescribing information; Prescription audit

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: J Pharm Health Care Sci Ano de publicação: 2017 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google